119 related articles for article (PubMed ID: 6350479)
1. [Etretinate in the prevention of recurrences of superficial bladder tumors. Clinical trial using the double-blind method].
Charbit L; Mangin P; Rognin C; Cukier J
J Urol (Paris); 1983; 89(4):247-9. PubMed ID: 6350479
[TBL] [Abstract][Full Text] [Related]
2. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
Alfthan O; Tarkkanen J; Gröhn P; Heinonen E; Pyrhönen S; Säilä K
Eur Urol; 1983; 9(1):6-9. PubMed ID: 6337054
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study].
Yoshida O; Miyakawa M; Watanabe H; Mishina T; Okajima E; Hirao Y; Matushima M; Nihira H; Nakatsu H
Hinyokika Kiyo; 1986 Sep; 32(9):1349-58. PubMed ID: 3544744
[TBL] [Abstract][Full Text] [Related]
4. Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland.
Studer UE; Biedermann C; Chollet D; Karrer P; Kraft R; Toggenburg H; Vonbank F
J Urol; 1984 Jan; 131(1):47-9. PubMed ID: 6361284
[TBL] [Abstract][Full Text] [Related]
5. Retinoids in superficial bladder tumours update.
Khoury S
Prog Clin Biol Res; 1984; 162B():347-54. PubMed ID: 6209722
[No Abstract] [Full Text] [Related]
6. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
7. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
[No Abstract] [Full Text] [Related]
8. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
Meffert H; Sönnichsen N
Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
[No Abstract] [Full Text] [Related]
9. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
Kingston TP; Matt LH; Lowe NJ
Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
[TBL] [Abstract][Full Text] [Related]
10. Oral retinoid for psoriasis. A report of a double blind study.
Pettit JH
Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland.
Studer UE; Jenzer S; Biedermann C; Chollet D; Kraft R; von Toggenburg H; Vonbank F
Eur Urol; 1995; 28(4):284-90. PubMed ID: 8575494
[TBL] [Abstract][Full Text] [Related]
12. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Bjerke JR; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
Burk K; Troller RM; Pittner P
Urologe A; 1983 Sep; 22 Suppl():332-6. PubMed ID: 6356556
[TBL] [Abstract][Full Text] [Related]
14. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
[TBL] [Abstract][Full Text] [Related]
15. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
[TBL] [Abstract][Full Text] [Related]
16. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
[TBL] [Abstract][Full Text] [Related]
17. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
Lassus A; Geiger JM
Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
[TBL] [Abstract][Full Text] [Related]
18. Etretinate in treatment of actinic keratosis. A double-blind crossover study.
Moriarty M; Dunn J; Darragh A; Lambe R; Brick I
Lancet; 1982 Feb; 1(8268):364-5. PubMed ID: 6120350
[TBL] [Abstract][Full Text] [Related]
19. Preventative effect of etretinate therapy on multiple actinic keratoses.
Watson AB
Cancer Detect Prev; 1986; 9(1-2):161-5. PubMed ID: 3524840
[TBL] [Abstract][Full Text] [Related]
20. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis.
Jakubowicz K; Gruca S; Nowakowski H
Acta Univ Carol Med (Praha); 1986; 32(3-4):229-32. PubMed ID: 3324721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
